MENU ABOUT US MAKE A DONATION
The Epoch Times
Login
SEARCH
CLOSE
Help Center subscribe newsletter Newsstands Epoch Shop Gift
  • TOP NEWS
  • SPECIAL SERIES
  • SPECIAL COVERAGE
  • LATEST ARTICLES
  • US
    • US News
    • US Features
    • US Politics
    • US Crime News
    • New York
    • San Francisco
    • Los Angeles
  • Opinion
    • Thinking About China
    • Viewpoints
    • Unbridled Evil: The Corrupt Reign of Jiang Zemin in China
    • The Reader’s Turn
  • China News
    • US-China Relations
    • Chinese Regime
    • Business & Economy
    • Chinese Culture
    • China Human Rights
    • Social Issues
    • Organ Harvesting in China
  • World News
    • Africa News
    • Americas
    • Asia & Pacific
    • Canada
    • Europe
    • UK News
    • Australia News
    • International
    • Middle East
  • Business & Markets
    • Companies
    • Economy
    • Markets
    • Real Estate
    • Gold and Commodities
  • ARTS & CULTURE
    • Fine Arts & Craftsmanship
    • Performing Arts
    • Books
    • Traditional Culture
    • Shen Yun Special Coverage
    • Film & TV
  • Science
    • News
    • Space
    • Environment
  • Tech
    • Tech News
    • Tech Products & Reviews
    • Social Media
  • Sports
  • Videos
    • American Thought Leaders
    • China Insider
    • Crossroads
  • Bright
    • Lifestyle
    • Inspired
    • Family & Education
    • Personal Finance
    • American Essence
  • Entertainment
    • Film & TV
    • Entertainment News
  • Health
    • Experts
    • Conditions
    • Life & Wellness
  • Special Topics
    • Battlefields
SEARCH
  • EpochTV
  • US
  • US Politics
  • Opinion
  • World News
  • China
  • Hong Kong
  • Health
  • Bright
  • Arts
  • Falun Gong
  • Premium
  • Markets
  • Games
  • Livestream
  • More

Novo Nordisk

  • Ozempic’s Sister Drug Reduces Cardiovascular Risk by 14 Percent in Large-Scale Trial
    Ozempic’s Sister Drug Reduces Cardiovascular Risk by 14 Percent in Large-Scale Trial
    Learn about the study's possible impact on treatment strategies.
    October 21, 2024BY George Citroner
  • Microsoft Hit With EU Antitrust Charge, Risks Hefty Fine; Tesla Recalls Cybertrucks | Business Matters Full Broadcast (June 25)
    Microsoft Hit With EU Antitrust Charge, Risks Hefty Fine; Tesla Recalls Cybertrucks | Business Matters Full Broadcast (June 25)
    Microsoft is in trouble with the EU over its popular collaboration app Teams, and could face a large ...
    June 25, 2024BY Don Ma
  • Novo Nordisk Sues 2 Pharmacies for Allegedly Selling Adulterated Weight-Loss Drugs
    Novo Nordisk Sues 2 Pharmacies for Allegedly Selling Adulterated Weight-Loss Drugs
    The company said it conducted tests on compounded drugs that claim to contain semaglutide and found 'concerning levels ...
    December 1, 2023BY Lorenz Duchamps
  • FDA Found Bacterial Contamination at Novo Nordisk Diabetes Pill Manufacturing Facility
    FDA Found Bacterial Contamination at Novo Nordisk Diabetes Pill Manufacturing Facility
    The contamination does not affect its popular weight loss drugs Wegovy and Ozempic, according to the company.
    September 26, 2023BY Naveen Athrappully
  • Weight-Loss Jab Wegovy Available for the First Time on NHS
    Weight-Loss Jab Wegovy Available for the First Time on NHS
    A limited supply of the loss jab drug Wegovy has become available to patients via NHS specialists in ...
    September 4, 2023BY Owen Evans
  • Thyroid Cancer Concerns Raised Regarding Active Ingredient in Popular Drugs Ozempic and Wegovy
    Thyroid Cancer Concerns Raised Regarding Active Ingredient in Popular Drugs Ozempic and Wegovy
    The European Medicines Agency (EMA) has issued a drug safety signal (pdf) regarding the potential risk of thyroid ...
    June 24, 2023BY Harry Lee
  • Thousands of Australians Face Skyrocketing Costs as Labor Price Cut Force Lifesaving Drug From PBS
    Thousands of Australians Face Skyrocketing Costs as Labor Price Cut Force Lifesaving Drug From PBS
    The federal government is under pressure from the Coalition after removing a key lifesaving drug from the pharmaceutical ...
    March 13, 2023BY Victoria Kelly-Clark
TOP NEWS
  • Trump on Iran Conflict: Troops Staying Until ‘We Have a Completion’
    NEW By T.J. Muscaro
    Trump on Iran Conflict: Troops Staying Until ‘We Have a Completion’
  • Iran Launches First Missiles at Israel Since Ceasefire Agreement
    2hr By Jacki Thrapp
    Iran Launches First Missiles at Israel Since Ceasefire Agreement
  • Israel Strikes Beirut Days After US-Supported Ceasefire Announcement
    3hr By Jack Phillips
    Israel Strikes Beirut Days After US-Supported Ceasefire Announcement
  • Former Utah Attorney General Fights the Evil That Lurks in Quiet Places
    3hr By Savannah Hulsey Pointer
    Former Utah Attorney General Fights the Evil That Lurks in Quiet Places
  • US Forces Shoot Down 2 Iranian Drones as Pakistani Interior Minister Visits Tehran
    5hr By Jacki Thrapp
    US Forces Shoot Down 2 Iranian Drones as Pakistani Interior Minister Visits Tehran
  • US Won’t Unfreeze Iran’s Assets Before Peace Deal Is Reached, Trump Says
    6hr By Jacki Thrapp
    US Won’t Unfreeze Iran’s Assets Before Peace Deal Is Reached, Trump Says
  • Fascia: The Living, Interconnected Web Behind Movement and Healing—How to Enhance Its Function
    6hr By Mercura Wang
    Fascia: The Living, Interconnected Web Behind Movement and Healing—How to Enhance Its Function
  • Eli Lilly Poised to Suspend Drug Discounts to Large Hospitals
    10hr By Lawrence Wilson
    Eli Lilly Poised to Suspend Drug Discounts to Large Hospitals
  • US Bankruptcy Filings Increase 7 Percent Yearly
    11hr By Naveen Athrappully
    US Bankruptcy Filings Increase 7 Percent Yearly
  • How a Tiny Insect Decimated Florida’s Citrus, and What Orchardists Are Doing About It
    12hr By Jacob Burg
    How a Tiny Insect Decimated Florida’s Citrus, and What Orchardists Are Doing About It
The Epoch Times
Copyright © 2000 - 2026 The Epoch Times Association Inc. All Rights Reserved.
Back Top